Clinical Trial Detail

NCT ID NCT01860638
Title A Comparison of Continuous Avastin (Bevacizumab) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Patients With Glioblastoma
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Lomustine

Age Groups: adult

No variant requirements are available.